Be alert if you experience a rash with Riboxil/Calilon

Skin rashes are common during use of Ribociclib, and most rashes are mild. However, since treatment needs to last for multiple cycles, skin changes should be taken seriously. Skin rashes caused by Riboxil are not entirely equivalent to "traditional allergies". Most of them are drug-related skin reactions, related to cell cycle inhibition and immune regulation changes. Therefore, they can usually be gradually improved through moisturizing, reducing irritation and symptomatic treatment.

Common symptoms of breast cancer patients include dry skin, mild red spots, itching or local rashes, which generally do not affect continued treatment. However, if the rash expands, blisters, pain, scaling, or is accompanied by fever, you should seek medical treatment as soon as possible. If necessary, the doctor will evaluate whether the dose needs to be reduced or the medication needs to be temporarily discontinued. In the overseas usage guidelines, rash is an adverse reaction that needs to be monitored but can be managed. The key is early detection and early treatment.

To reduce the risk of rash, patients are advised to keep their skin moisturized throughout treatment, avoid excessive sun exposure, and reduce the use of hot water and harsh skin care products. Also avoid scratching, which can lead to further skin damage or infection. If the itching is significant, you can use mild topical repair products or antihistamines under the guidance of your doctor.

The most important thing is not to stop taking medication because of a rash. Riboxiclib emphasizes continuous periodic treatment, and unauthorized interruption may affect the overall efficacy. As long as the rash is treated in time, most cases can be recovered without affecting the long-term treatment plan.

In general, the occurrence of rash on Riboxil requires vigilance, but there is no need to panic. Most rashes are controllable and can be effectively resolved through standardized skin care and timely feedback to the doctor, making treatment more stable and safer.

Reference materials:https://us.kisqali.com/